Influence of disease-modifying antirheumatic drugs on oxidative and nitrosative stress in patients with rheumatoid arthritis

被引：0
|
作者：
Neide Tomimura Costa
Tatiana Mayumi Veiga Iriyoda
Daniela Frizon Alfieri
Andréa Name Colado Simão
Isaias Dichi
机构：
[1] University of Londrina,Department of Rheumatology
[2] Pontifícia Universidade Católica (PUC),Department of Rheumatology
[3] University of Londrina,Research Laboratory of Applied Immunology
[4] University of Londrina,Department of Pathology, Clinical Analysis and Toxicology
[5] University of Londrina,Department of Internal Medicine
来源：
Inflammopharmacology | 2018年 / 26卷
关键词：
Disease-modifying antirheumatic drugs; Rheumatoid arthritis; Oxidative stress; Nitrosative stress;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1151 / 1164
页数：13
相关论文
共 50 条
  • [1] Influence of disease-modifying antirheumatic drugs on oxidative and nitrosative stress in patients with rheumatoid arthritis
    Costa, Neide Tomimura
    Veiga Iriyoda, Tatiana Mayumi
    Alfieri, Daniela Frizon
    Colado Simao, Andrea Name
    Dichi, Isaias
    [J]. INFLAMMOPHARMACOLOGY, 2018, 26 (05) : 1151 - 1164
  • [2] Survival of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis
    Rosales Rosado, Zulema
    Leon, Leticia
    Freites Nunez, Dalifer
    Font Urgelles, Judit
    Leon Cardenas, Cynthia Milagros
    Vadillo Font, Cristina
    Rodriguez Rodriguez, Luis
    Jover Jover, Juan A.
    Abasolo Alcazar, Lydia
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [3] Treatment failure with disease-modifying antirheumatic drugs in rheumatoid arthritis patients
    Mittal, Niti
    Mittal, Rakesh
    Sharma, Aman
    Jose, Vinu
    Wanchu, Ajay
    Singh, Surjit
    [J]. SINGAPORE MEDICAL JOURNAL, 2012, 53 (08) : 532 - 536
  • [4] Disease-modifying antirheumatic drugs and bone mass in rheumatoid arthritis
    Di Munno, O
    Delle Sedie, A
    Rossini, A
    Adamil, S
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2005, 23 (02) : 137 - 144
  • [5] Conventional disease-modifying antirheumatic drugs to treat rheumatoid arthritis
    Rath, T.
    Sander, O.
    Rubbert, A.
    [J]. DRUG DEVELOPMENT RESEARCH, 2011, 72 (08) : 657 - 663
  • [6] Safety of biological disease-modifying antirheumatic drugs in rheumatoid arthritis
    Martinez-Mugica, Cristina
    Salgueiro, Esther
    [J]. FARMACIA HOSPITALARIA, 2022, 46 (01) : 15 - 20
  • [7] DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARD) IN THE TREATMENT OF PATIENTS WITH RHEUMATOID-ARTHRITIS
    HALBERG, P
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1986, : 55 - 57
  • [8] The Efficacy of Biological Disease-modifying Antirheumatic Drugs on Sarcopenia in Patients with Rheumatoid Arthritis
    Hasegawa, Eriko
    Ito, Satoshi
    Kurosawa, Yoichi
    Kobayashi, Daisuke
    Otani, Hiroshi
    Abe, Asami
    Nakazono, Kiyoshi
    Murasawa, Akira
    Narita, Ichiei
    Ishikawa, Hajime
    [J]. INTERNAL MEDICINE, 2023, 62 (03) : 373 - 379
  • [9] Disease-modifying antirheumatic drugs in rheumatoid arthritis patients with a history of colorectal cancer
    Kleinert, S.
    Waldner, M.
    Wendler, J.
    Kunzmann, V.
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2016, 75 (01): : 41 - 46
  • [10] Utilization Patterns of Disease-Modifying Antirheumatic Drugs in Elderly Rheumatoid Arthritis Patients
    Jin, Xue-Mei
    Lee, Joongyub
    Choi, Nam-Kyong
    Seong, Jong-Mi
    Shin, Ju-Young
    Kim, Ye-Jee
    Kim, Mi-Sook
    Yang, Bo Ram
    Park, Byung-Joo
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2014, 29 (02) : 210 - 216
12345